Atorvastatin Calcium is an HMG-CoA reductase inhibitor (statin) indicated for primary hyperlipidemia, mixed dyslipidemia and reduction of cardiovascular risk. We supply it to US manufacturers of tablets.
Data from PubChem (CID 60822) and FDA’s substance registry
CAS number
134523-03-8
Molecular formula
C66H68CaF2N4O10
Molecular weight
1155.3g/mol
FDA UNII
IUPAC name
calcium bis((3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate)
InChIKey
FQCKMBLVYCEXJB-MNSAWQCASA-L
- Appearance
- White to off-white powder.
- Solubility
- Insoluble in aqueous solutions of pH 4 and below, and very slightly soluble in water. Freely soluble in methanol and slightly soluble in ethanol.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Supplied as the crystalline trihydrate or as amorphous material. The two differ in solubility and stability and are covered by separate DMFs, so state the form you developed with.
On the US market
- Reference product
- LipitorNDA 020702
- Approved ANDAs
- 24 with a marketed product
- Approved forms and strengths
- Tablet 10 mg, 20 mg, 40 mg, 80 mg
- Oral suspension 20 mg/5 mL
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com